Mendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 811×Preview0:00Current time: 0:00 / Total time: -8:12-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid81ShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesTheranos Had the Vision. Truvian Has the Execution. Our Chat with CEO Jay SrinivasanOct 14 • Theral TimpsonPhysicians Don't Want a Laundry List of Genes says Premal Shah, CEO of MyomeOct 7 • Theral TimpsonThe Customer Case for iconPCR with Stefan Green and Yann JouvenotOct 2 • Theral TimpsonAlex Dickinson on Long Read Sequencing, Multi Omics, and the Next Frontier in GenomicsSep 30 • Theral TimpsonRapid Answers for Rare Disease: Katherine Stueland on GeneDx’s MissionSep 25 • Theral TimpsonMoran Snir's Vision for Making Genomic Care Routine across the U.S.Sep 23 • Theral TimpsonHow Certis Is Rewriting Cancer Models with CEO Peter EllmanSep 18 • Theral TimpsonMyriad’s Next Chapter: New CEO Sam Raha on Growth, AI, and MRD TestingSep 16 • Theral Timpson